[1] Keitel V, Droge C,Stepanow S,et al.Intrahepatic cholestasis of pregnancy (ICP): case report and review of the literature.Gastroenterol, 2016,54:1327-1333.
[2] 江杰妮,李佳平,陈小凤,等.妊娠期肝内胆汁淤积症药物治疗机制及进展.中国妇幼健康研究,2019,30:378-381.
[3] 杨德红,邵庆华.丁二磺酸腺苷蛋氨酸联合多烯磷脂酰胆碱治疗妊娠期肝内胆汁淤积症的疗效观察.肝脏,2018,23:357-359.
[4] 金雨慧,吕杰强.妊娠期肝内胆汁瘀积症对血脂代谢的影响及地塞米松联合腺苷蛋氨酸疗效.临床荟萃,2014,29:1005-1007,1011.
[5] 贺晶,杨慧霞,段涛,等.妊娠期肝内胆汁淤积症诊疗指南(2015).临床肝胆病杂志,2015,31:1575-1578
[6] He Y,Zhang L,Zhu Z,et al.Blockade of cyclophilin D rescues dexamethasone-induced oxidative stress in gingival tissue.PLoS One, 2017,12:e0173270.
[7] Ribalta J,Reyes H,Gonzalez MC,et al.S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy:a randomized,double－blind,placebo－controlled study with negative results .Hepatology,1991,13:1084-1089.
[8] 李华,张利平,高霞,等.地塞米松联合熊脱氧胆酸治疗妊娠期肝内胆汁淤积的临床疗效及对血清PLTP、IL-18 水平的影响.河北医学,2018,24:1254-1257.
[9] 刘莉萍,宣荣荣,朱虹,等.地塞米松辅助治疗对妊娠期肝内胆汁淤积症患者免疫功能、肝功能的影响.中国全科医学,2018,16:2049-2051,2091.
[10] 申铁英,郭秀云,罗万翠.地塞米松联合腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的疗效及对患者肝功能、炎性细胞因子水平的影响.中国妇幼保健,2017,32:4333-4336. |
